The Journal of Nuclear Medicine - JNM

Home
United States
Reston, VA
The Journal of Nuclear Medicine - JNM

Founded in 1960, The Journal of Nuclear Medicine is the world’s leading nuclear medicine, molecular i

According to new data announced by Clarivate in the 2020 Journal Citation Reports™ (released in June 2021), JNM ranks third in impact among 134 medical imaging journals worldwide. Impact factor – 10.057
Five-year impact factor – 8.573
Immediacy index – 4.011
Total citations – 32,949
Eigenfactor Score – 0.03249
Article Influence Score – 2.19

08/19/2026

The OPTIMAL-PSMA trial aims to determine whether a dose-intensified regimen of ¹⁷⁷Lu-PSMA-597 is safe and improves response and survival outcomes compared with the standard dosing regimen. Learn more: https://ow.ly/ZjpF50ZzP7Q

08/17/2026

Neuroinflammatory PET in epilepsy: Prospects for epileptogenic zone localization and presurgical planning. https://ow.ly/w95450ZzP5t

08/14/2026

Letter to the Editor: Concerns Regarding Brain ¹⁸F-FDG SUVmean as a Prognostic Biomarker in Advanced Non–Small Cell Lung Cancer. https://ow.ly/iitP50ZzP3w

08/10/2026

Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging workgroup: https://ow.ly/eLLX50Zssca

08/06/2026

Temporal ¹⁸F-PI-2620 binding is associated with genetic Alzheimer’s disease risk, plasma p-tau₂₁₇, female s*x, and episodic memory deficits in cognitively unimpaired. older adults. https://ow.ly/Kb3O50Zssba

08/04/2026

Clonal hematopoiesis is highly prevalent and tends to lead to greater hematologic toxicity in patients with mCRPC receiving LuPSMA. https://ow.ly/bGh450Zss5B

07/31/2026

Discussions with Leaders: An immunologist’s path toward advancing the scientific mission of the Prostate Cancer Foundation. https://ow.ly/QWcF50Zss4l

07/29/2026

2025 SNMMI Basic Sciences Summary Session Highlight Lectures: Physics, Instrumentation, and Data Sciences: https://ow.ly/jMQ850Zss3G

07/27/2026

The PROFILE score offers valuable prognostic information for patients with metastatic castration-resistant prostate cancer when considering the use of ¹⁷⁷Lu-PSMA-617 therapy. Learn more: https://ow.ly/BgLg50Zss2h

07/23/2026

PSMA PET/CT–guided targeted biopsy enhances clinically significant prostate cancer detection in men with negative or equivocal mpMRI, with added predictive value from SUVₘₐₓ and dynamic PET metrics. https://ow.ly/7To950ZnZXo

Address

Reston, VA
20190

Website

http://jnm.snmjournals.org/

Alerts

Be the first to know and let us send you an email when The Journal of Nuclear Medicine - JNM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Reston?